More precisely, it is possible to highlight with 2C5 sdAb a punctiform labeling of the Tau oligomers in the neurons at an early stage of the disease, as well as the fibrillar forms in more advanced AD stages. The gene discussed is MAPT; the disease is Alzheimer disease.